Researchers at the Wyss Insti­tute for Bio­log­i­cally Inspired Engi­neering at Har­vard Uni­ver­sity have devel­oped a novel bio­mimetic strategy that delivers life-​​saving nan­oth­er­a­peu­tics directly to obstructed blood ves­sels, dis­solving blood clots before they cause serious damage or even death. This new approach enables thrombus dis­so­lu­tion while using only a frac­tion of the drug dose nor­mally required, thereby min­i­mizing bleeding side effects that cur­rently limit wide­spread use of clot-​​busting drugs.

Read the article at Science Daily →